You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The third set of papers out this week from The Cancer Genome Atlas touches on ways to cluster tumors, oncogenic processes that contribute to oncogenesis, and more.
As part of the agreement, a precision cancer research and treatment institute will be created at the Windber facilities.
BioServe touts the repository as the "the largest resource of high-quality biosamples for the life science industry" and claims that researchers can access it to garner biosamples from "most any major diseases."
The firm has started the BioServe Network with partners including Fox Chase, Windber, UMass, and the Fairbanks Institute for Healthy Communities.
BioServe will supplement its clinical-grade biospecimens in its Global BioRepository with biosamples from the Windber Research Institute's Tissue Bank.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.